| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Over the last 12 months, insiders at SAB Biotherapeutics, Inc. have bought $0 and sold $0 worth of SAB Biotherapeutics, Inc. stock.
On average, over the past 5 years, insiders at SAB Biotherapeutics, Inc. have bought $16,743 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,740 shares for transaction amount of $1,531 was made by Sullivan Eddie Joe (Chief Executive Officer) on 2023‑12‑07.
| 2023-12-07 | Sullivan Eddie Joe | Chief Executive Officer | 1,740 0.0034% | $0.88 | $1,531 | -63.29% | ||
| 2023-11-30 | King Michael | CHIEF FINANCIAL OFFICER | 5,000 0.0088% | $0.90 | $4,500 | -65.12% | ||
| 2023-11-29 | Reich Samuel J | Executive Chairman | 11,000 0.0209% | $0.89 | $9,842 | -61.03% | ||
| 2022-09-13 | HAMILTON CHRISTINE E | 10,000 0.0239% | $0.73 | $7,297 | +9.70% | |||
| 2022-09-07 | Sullivan Eddie Joe | CHIEF EXECUTIVE OFFICER | 14,000 0.0352% | $0.74 | $10,315 | +14.54% | ||
| 2021-10-26 | Sale | Beyer Russell P | Chief Financial Officer | 278 0.0005% | $7.90 | $2,196 | -79.14% | |
| 2021-10-14 | Reich Samuel J | CEO and CFO | 1,000 0.0023% | $10.11 | $10,110 | -77.38% | ||
| 2021-10-13 | Katz Ilan | 500 0.0012% | $10.11 | $5,053 | -77.23% | |||
| 2021-10-01 | Spragens Jeffrey G | director | 13,000 0.0299% | $10.07 | $130,910 | -74.98% | ||
| 2021-10-01 | Katz Ilan | 1,000 0.0023% | $10.09 | $10,090 | -74.98% | |||
| 2021-01-14 | Reich Samuel J | CEO and CFO | 417,200 0.9455% | $10.00 | $4.17M | |||
| 2021-01-14 | Katz Ilan | 417,200 0.9455% | $10.00 | $4.17M | ||||
| 2021-01-14 | Big Cypress Holdings LLC | CEO and CFO | 417,200 0.9455% | $10.00 | $4.17M |
| Sullivan Eddie Joe | Chief Executive Officer | 5232304 5.7506% | $16.32M | 2 | 0 | <0.0001% |
| HAMILTON CHRISTINE E | 4993090 5.4877% | $15.58M | 1 | 0 | +9.7% | |
| Big Cypress Holdings LLC | CEO and CFO | 3047825 3.3498% | $9.51M | 1 | 0 | |
| Reich Samuel J | Executive Chairman | 219001 0.2407% | $683,283.12 | 3 | 0 | <0.0001% |
| Spragens Jeffrey G | director | 13000 0.0143% | $40,560.00 | 1 | 0 | <0.0001% |
| King Michael | CHIEF FINANCIAL OFFICER | 5000 0.0055% | $15,600.00 | 1 | 0 | <0.0001% |
| Katz Ilan | 1500 0.0016% | $4,680.00 | 3 | 0 | <0.0001% |
$60,836,085 | 69 | 0.45% | $255.44M | |
$64,733,831 | 40 | 5.69% | $299.32M | |
$140,595,157 | 34 | 17.93% | $301.23M | |
$109,019,806 | 28 | 7.37% | $263.86M | |
$104,171,521 | 16 | 20.21% | $275.53M |
| Increased Positions | 32 | +94.12% | 10M | +35.55% |
| Decreased Positions | 11 | -32.35% | 2M | -5.86% |
| New Positions | 21 | New | 8M | New |
| Sold Out Positions | 7 | Sold Out | 2M | Sold Out |
| Total Postitions | 55 | +61.76% | 36M | +29.68% |
| Vivo Capital, Llc | $43,053.00 | 23.79% | 11.42M | +11M | New | 2025-09-30 |
| Commodore Capital Lp | $16,594.00 | 9.17% | 4.4M | +4M | New | 2025-09-30 |
| Ra Capital Management, L.P. | $16,594.00 | 9.17% | 4.4M | +4M | New | 2025-09-30 |
| Woodline Partners Lp | $10,748.00 | 5.94% | 2.85M | +3M | New | 2025-09-30 |
| Sessa Capital Im, L.P. | $8,288.00 | 4.58% | 2.2M | +2M | +379.53% | 2025-09-30 |
| Bvf Inc/Il | $3,516.00 | 1.94% | 932,697 | +14,871 | +1.62% | 2025-09-30 |
| Sphera Funds Management Ltd. | $2,135.00 | 1.18% | 566,395 | +566,395 | New | 2025-09-30 |
| Vanguard Group Inc | $1,379.00 | 0.76% | 365,753 | +83,382 | +29.53% | 2025-09-30 |
| Hb Wealth Management, Llc | $1,159.00 | 0.64% | 307,500 | +307,500 | New | 2025-09-30 |
| Awm Investment Company, Inc. | $754.00 | 0.42% | 200,000 | +200,000 | New | 2025-09-30 |